[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DD142962A5 - Stabilisierungsverfahren - Google Patents

Stabilisierungsverfahren Download PDF

Info

Publication number
DD142962A5
DD142962A5 DD79212450A DD21245079A DD142962A5 DD 142962 A5 DD142962 A5 DD 142962A5 DD 79212450 A DD79212450 A DD 79212450A DD 21245079 A DD21245079 A DD 21245079A DD 142962 A5 DD142962 A5 DD 142962A5
Authority
DD
German Democratic Republic
Prior art keywords
mixture
cmt
base
decomposition
carrier substance
Prior art date
Application number
DD79212450A
Other languages
German (de)
English (en)
Inventor
Horst Felsch
Gerhard Hantich
Original Assignee
Pharmaceutical Licences Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaceutical Licences Co filed Critical Pharmaceutical Licences Co
Publication of DD142962A5 publication Critical patent/DD142962A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lubricants (AREA)
DD79212450A 1978-04-25 1979-04-24 Stabilisierungsverfahren DD142962A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT296178A AT358530B (de) 1978-04-25 1978-04-25 Stabilisierungsverfahren

Publications (1)

Publication Number Publication Date
DD142962A5 true DD142962A5 (de) 1980-07-23

Family

ID=3543124

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79212450A DD142962A5 (de) 1978-04-25 1979-04-24 Stabilisierungsverfahren

Country Status (23)

Country Link
US (1) US4247702A (fr)
EP (1) EP0005121B1 (fr)
JP (1) JPS54147914A (fr)
AT (1) AT358530B (fr)
AU (1) AU523518B2 (fr)
CA (1) CA1113941A (fr)
CS (1) CS208779B2 (fr)
DD (1) DD142962A5 (fr)
DE (2) DE2963835D1 (fr)
DK (1) DK155978C (fr)
ES (1) ES480590A1 (fr)
FI (1) FI66120C (fr)
GR (1) GR66987B (fr)
HU (1) HU179741B (fr)
IE (1) IE48778B1 (fr)
IL (1) IL57292A (fr)
NO (1) NO150317C (fr)
NZ (1) NZ190240A (fr)
PT (1) PT69532A (fr)
SU (1) SU959626A3 (fr)
UA (1) UA5545A1 (fr)
YU (1) YU42302B (fr)
ZA (1) ZA791661B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58159425A (ja) * 1982-03-18 1983-09-21 Fujisawa Pharmaceut Co Ltd ゲル基剤
SE9303281D0 (sv) * 1993-10-07 1993-10-07 Astra Ab New formulation
DE60039727D1 (de) 1999-10-15 2008-09-11 Sucampo Ag Neue Zusammensetzung enthaltend eine bicyclische Verbindung und ein Glycerid
US9884024B2 (en) * 2005-12-27 2018-02-06 Hemant N Joshi Physically dispersed, molecularly dissolved and/or chemically bound drug(s) in an empty, hard capsule shell composition
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2844512A (en) * 1954-11-05 1958-07-22 Upjohn Co Fumagillin enveloped in fatty or waxy substance and enclosed in ultraviolet opaque container
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
FR1536904A (fr) * 1962-12-19 1968-09-02 Smith Kline French Lab Procédé de préparation de pilules pharmaceutiques à libération progressive de leur principe actif
SE319577B (fr) * 1966-03-08 1970-01-19 Astra Ab
JPS4971127A (fr) * 1972-11-18 1974-07-10
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.
NL7510104A (nl) * 1975-08-27 1977-03-01 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
DE2631281A1 (de) * 1976-07-12 1978-01-19 Kali Chemie Pharma Gmbh Verfahren zur erhoehung der loeslichkeit von schwerloeslichen arzneistoffen zum zwecke deren applikation in gelatinekapseln
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof

Also Published As

Publication number Publication date
CS208779B2 (en) 1981-09-15
FI66120C (fi) 1984-09-10
YU91079A (en) 1984-10-31
CA1113941A (fr) 1981-12-08
PT69532A (de) 1979-05-01
DK167879A (da) 1979-10-26
DE2916573C2 (de) 1982-09-02
IE48778B1 (en) 1985-05-15
YU42302B (en) 1988-08-31
EP0005121A2 (fr) 1979-10-31
UA5545A1 (uk) 1994-12-28
AU4637379A (en) 1979-11-01
ATA296178A (de) 1980-02-15
JPS6337791B2 (fr) 1988-07-27
JPS54147914A (en) 1979-11-19
AT358530B (de) 1980-09-10
AU523518B2 (en) 1982-07-29
US4247702A (en) 1981-01-27
ES480590A1 (es) 1980-08-16
DK155978C (da) 1989-10-30
EP0005121A3 (en) 1979-11-28
FI66120B (fi) 1984-05-31
DK155978B (da) 1989-06-12
IE790836L (en) 1979-10-25
HU179741B (en) 1982-12-28
NZ190240A (en) 1980-10-24
GR66987B (fr) 1981-05-15
NO150317C (no) 1984-09-26
NO150317B (no) 1984-06-18
FI791324A (fi) 1979-10-26
SU959626A3 (ru) 1982-09-15
IL57292A (en) 1982-11-30
DE2916573A1 (de) 1979-10-31
NO791339L (no) 1979-10-26
EP0005121B1 (fr) 1982-10-13
DE2963835D1 (en) 1982-11-18
ZA791661B (en) 1980-04-30

Similar Documents

Publication Publication Date Title
DE1617430C3 (de) Schäumende lagerstabile Zahnpaste
EP0880352B1 (fr) Stabilisation de chlorhydrate de naloxone
DE2905979C2 (de) Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
DE10249552A1 (de) Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
DE2418338A1 (de) Kosmetische mittel mit desodorierender wirkung
DE2418362B2 (de) Verwendung aliphatischer Hydroxycarbonsäureester als Desodorantien in kosmetischen Zubereitungen
DE3042332A1 (de) Waessrige nitroglycerinloesung
DE2709229A1 (de) Aerosoltreibmittel
EP0235528B1 (fr) Procédé de préparation d'huiles ozonisées stables à partir d'huiles végétales insaturées
DE3854121T2 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE2826757C2 (fr)
DD142962A5 (de) Stabilisierungsverfahren
EP0339382B1 (fr) Procédé pour désodoriser des mélanges d'esters d'acides gras
DE2042323A1 (de) Blutbildendes Präparat
DE2126533A1 (de) Verfahren zur Herstellung pharma zeutischer Zubereitungen
EP0006234A1 (fr) L'utilisation comme déodorants d'une combinaison d'esters d'acide citrique et/ou d'acide acétyl-citrique avec des antioxydants
AT392904B (de) Verfahren zur herstellung einer zur oralen verabreichung von etoposid bestimmten weichgelantinekapsel
EP0591710B1 (fr) Solutions injectable contenant du mesna
DE2629694B2 (de) Zwischenkondensat zur Herstellung eines Dentalpräparates zum Abdecken des Zahnmarks und zur Wurzelkanalfüllung
DE2602907C2 (de) Röntgenkontrastmittel auf der Basis einer Emulsion von jodierten ölen
DE2743586A1 (de) Injizierbare loesung und verfahren zur herstellung derselben
DE1231847B (de) Verfahren zur Herstellung von parenteral applizierbaren waessrigen Loesungen von substituierten Benzochinonen
DE1518057B2 (de) Injizierbares adrenocorticotropes hormonpraeparat mit prolongierter acthaktivitaet
DE2826759A1 (de) Verwendung einer kombination von estern ein- und zweibasischer aliphatischer hydroxycarbonsaeuren mit antioxidantien als deodorantien
DE3305689A1 (de) Pharmazeutische zubereitung mit retardwirkung